Counterfeit or sub-standard, anti-infective drugs are a widespread and under-recognised problem, increasing the resistance of diseases to treatment and undermining trust in health care in the developing world, researchers warned in a study published on Monday.

"Much more needs to be done now to improve this enormous, yet neglected problem that affects particularly the poorest, most vulnerable people," warned Paul Newton from Mahosot Hospital, Vientiane, Laos, one of the report's authors.

21 August 2006

Read the full story at